Berkeley, California, USA, May 9, 2019- Bayer’s new global manufacturing site in California will rely on GE Healthcare’s FlexFactory™ platform. At a groundbreaking event at the Berkeley, California site, Bayer announced its intention to manufacture biologic therapies for multiple patient populations. Fluor, an engineering and construction company, is providing a single point of responsibility for... Read more
Nottingham, UK – 24th April 2019 – BioCity, a pioneering life science incubator and business collective, today announced investment in Deep Branch Biotechnology, a Nottingham-based carbon recycling start-up, developing technology that transforms polluters into producers. Unlike traditional carbon storage technology that simply collects and stores carbon dioxide, Deep Branch’s carbon recycling solution converts carbon dioxide... Read more
WALTHAM, Mass., May 1, 2019 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has completed its previously announced acquisition of Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies, for approximately $1.7 billion in cash. The completion of the transaction follows the... Read more
April 30, 2019 MilliporeSigma develops fully equipped Center for Microbiological Analysis Training lab Food safety scientists to be trained in microbiological testing Ghaziabad, India, April 30, 2019 — MilliporeSigma, a leading science and technology company, today announced the handover of a fully equipped microbiological testing laboratory to the Food Safety and Standards Authority of India (FSSAI).... Read more
Agilent and SomaLogic Sign Agreement for Supply of Custom Microarrays Use of Agilent’s custom microarrays in the SOMAscan® assay will help drive biomarker discovery efforts as well as novel diagnostics and accelerated pharmaceutical development SANTA CLARA, Calif., & BOULDER, Colo., April 30, 2019 Agilent Technologies Inc. (NYSE: A) and SomaLogic, Inc. (a privately held biotechnology... Read more
April 29, 2019 Simultaneously Closes Strategic Growth Investment from Ampersand Capital to Create a Leading Provider of Genomic and Cell and Tissue Analysis Products and Services ST. LOUIS — Canopy BiosciencesTM, LLC, a leading provider of gene editing and gene expression products and services, announced today that it has acquired Zellkraftwerk GmbH, a leader in... Read more
Basel, 26 April 2019 Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc. Withdrawing and refiling the Premerger Notification and Report Form provides additional time for government to complete regulatory review Roche (SIX: RO,... Read more
Thu 25th April 2019 Strategic collaboration between two organisations represents largest nanopore sequencing project to date, capitalising on recent developments bringing ultra-high yields with PromethION GrandOmics, a leading sequencing company in China, has announced a populational-scale project, dbSV100k, to understand the impact of structural variation on human disease. The project aims to sequence 20,000 human... Read more
APRIL 22, 2019 SHANGHAI and MINNEAPOLIS, April 22, 2019 /PRNewswire/ — Elpiscience BioPharma and Bio-Techne Corporation announced today that the companies have entered into a strategic collaboration for the development of anti-cancer therapeutics. Under the terms of the agreement, Elpiscience will have access to multiple antibodies from Bio-Techne’s extensive product portfolio for use in the development of preclinical, clinical, and commercial... Read more
Apr 16, 2019 iGEM teams benefit from accessible synthesis with free IDT products and support CORALVILLE, IA and BOSTON, MA (April 16, 2019) – As an advocate for researchers in synthetic biology, Integrated DNA Technologies (IDT) is once again proudly partnering with the International Genetically Engineered Machine (iGEM) Foundation to support young researchers and promote scientific progress. IDT... Read more